The STUDIA UNIVERSITATIS BABEŞ-BOLYAI issue article summary

The summary of the selected article appears at the bottom of the page. In order to get back to the contents of the issue this article belongs to you have to access the link from the title. In order to see all the articles of the archive which have as author/co-author one of the authors mentioned below, you have to access the link from the author's name.

  
       
         
    STUDIA OECONOMICA - Issue no. 1 / 2007  
         
  Article:   STRATEGIC ASPECTS OF GLOBAL PHARMACEUTICAL INDUSTRY.

Authors:  ANDREJ BERTONCELJ, DRAGAN KESIČ. 		 
       
         
  Abstract:  Globalisation process has increased competition among pharmaceutical companies and caused a fierce fight for global market share and customers’ loyalty. Nowadays, pharmaceutical industry faces new strategic challenges as a number of newly launched innovative blockbuster products is steadily decreasing despite heavy multi billion dollar investments in research and development. Intensive process of concentration is taking place in all there industry segments - originators, generic companies and specialists. Further consolidation of the industry on the global scale can be realistically forecasted as the competition for tomorrow will be predominantly among coalition of companies and stand-alone companies. Global pharmaceutical companies will cooperate and compete at the same time. Globalisation process will further spur mergers and acquisitions in the pharmaceutical industry and we will see even bigger pharmaceutical conglomerates and more oligopolisation in the future.

Keywords: global pharmaceutical industry, originators, generic pharmaceutical industry, oligopolisation, consolidation 		 
         
     
         
         
      Back to previous page